Home Search

COVID-19 - search results

If you're not happy with the results, please do another search
life expectancy

Life expectancy in England declining long before the COVID-19 pandemic

A study conducted by Imperial College London has revealed that the life expectancy in England had  been falling in many regions of the country...
COVID-19 infection

Innovative model predicts COVID-19 infection risk in the workplace

A collaboration of UK scientists have developed a cutting-edge predictive model that can accurately assess the risk of COVID-19 infection in office and school...
pregnant women

Vaccine hesitancy: Protecting pregnant women against COVID-19

Dr Patrick O’Brien, Vice President of the Royal College of Obstetricians and Gynaecologists, discusses vaccine hesitancy among pregnant women. On average, it takes a decade...
vaccinating children

Exploring the issues surrounding vaccinating children against COVID-19

As the US and many European countries start vaccinating children against COVID-19, should more be done to prioritise those beyond our borders? Dominic Wilkinson,...
physical activity

COVID-19 negatively impacts physical activity levels for older adults

Luke Price, Senior Programme Manager at the Centre for Ageing Better, spoke to Health Europa about the physical activity levels for older adults during...
C-reactive protein

CRP rapid testing for suspected COVID-19 could slow the spread of antimicrobial resistance

Dr Carl Llor reviews recent evidence that C-reactive protein (CRP) rapid testing can be used as a prognostic marker in COVID-19 and contribute to...
UVA light treatment

Harnessing the benefits of UVA light treatment in COVID-19 patients

Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells

Trial begins for world-first multivariant COVID-19 vaccine booster

A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester. Initiated by pharmaceutical company Gritstone, in partnership with...
COVID-19 booster vaccines

Health experts believe COVID-19 booster vaccines are not yet required

A group of industry-leading health experts has concluded that COVID-19 booster vaccines are not yet needed to combat the pandemic. The international team of scientists,...
gout medication

Commonly prescribed gout medication found effective against COVID-19

A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon...
COVID-19 variants

COVID-19 variants will require infection control measures post-vaccination

Even after the implementation of widespread vaccination protocols, robust infection control measures will need to be enforced to prevent the spread of COVID-19 variants,...
organ-transplants-COVID-19

Organ transplants fell by a third during first wave of COVID-19

The number of solid organ transplants performed globally dropped by 31% during the first wave of the COVID-19 pandemic, a new study has revealed. Research...
COVID-19-patients

Experts warn COVID-19 recovery could take longer than a year

Around one half of patients who were hospitalised with COVID-19 still experience health issues related to the virus after one year, a study has...
pregnancy-COVID-pre-eclampsia

COVID-19 infection in pregnancy linked to higher risk of pre-eclampsia

Contracting COVID-19 during pregnancy can increase a woman’s risk of developing pre-eclampsia, researchers have demonstrated. A review of scientific literature by researchers in Brazil has...
virtual-reality-training-COVID-19

Virtual reality training launched for COVID-19 labs to tackle skills shortage

A new virtual reality training programme has been introduced for COVID-19 laboratories in the hope of meeting a mass skills shortage. Educational technology innovator CREDERSI...
breathing-device

Prototype breathing device created for COVID-19 patients in poor countries

Experts have developed a low-cost and easy-to-use prototype breathing device, designed specifically for poorer-resourced healthcare settings. Created in response to the surge of COVID-19 cases...
antibody

COVID-19 antibody surveillance programme launched in the UK

A new antibody surveillance scheme will be introduced in the UK to improve understanding of immunity against COVID-19 from vaccination and infection. Launching on Tuesday...
delta-variant

COVID-19 vaccines are still effective against Delta variant, study confirms

Two COVID-19 vaccine doses provide the most effective protection from the Delta variant in the UK, a new study has shown. Researchers from the University...
cannabis-Australia

Cannabis use in Australia rose significantly during first COVID-19 lockdown

Cannabis use in Australia spiked during the first COVID-19 lockdown period whilst methamphetamine use fell dramatically, a study has found. Research led by the University...
Bells-palsy-covid-vaccines

COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers

The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said. Following the first large-scale population-based study...

Pin It on Pinterest